Dual PET and SPECT imaging

The ability to simultaneously monitor metabolism and biological markers in vivo has profound implications for clinical and small animal imaging. Current stand-alone imaging devices capable of these measurements include positron emission tomography (P ET) and single-photon emission computed tomography (SPECT). PET provides tissue metabolism information and high resolution but can not handle multiple tracers. SPECT allows multiple tracers for additional information but can not provide tissue metab olism data and is not as quantitative as PET. Researchers at the University at Buffalo have developed a hybrid PET/SPECT device that combines the benefits of both. The device and software easily retrofits existing PET scanners and provides SPECT imag ing capability using the same detectors, a common bed, and a combined software platform. This is done without compromising stand-alone PET or stand-alone SPECT images and does so concurrently. It offers a substantial cost savings over purchasing both systems. By combining the benefits of both imaging systems, the dual PET/SPECT device enables new avenues for therapeutic or diagnostic monitoring both clinically and in new drug development.

Categories: Imaging: Medical Imaging

Type of Offer: Licensing



« More Medical Patents

---